Average Co-Inventor Count = 4.70
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Adimab, LLC (13 from 48 patents)
2. Merrimack Pharmaceuticals, Inc. (10 from 52 patents)
3. Seagen Inc. (4 from 64 patents)
4. Genentech, Inc. (3 from 3,221 patents)
5. Celldex Therapeutics Limited (1 from 45 patents)
6. Torque Therapeutics, Inc. (1 from 4 patents)
29 patents:
1. 12071480 - CD47 antibodies and uses thereof for treating cancer
2. 12018403 - Antibody libraries
3. 11767365 - BCMA antibodies and use of same to treat cancer and immunological disorders
4. 11746160 - Antibodies against BACE1 and use thereof for neural disease immunotherapy
5. 11471490 - T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
6. 11180552 - CD47 antibodies and uses thereof for treating cancer
7. 11091559 - Anti-ALK antibodies and methods for use thereof
8. 11078291 - BCMA antibodies and use of same to treat cancer and immunological disorders
9. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
10. 11008383 - Rationally designed, synthetic antibody libraries and uses therefor
11. 11008568 - Rationally designed, synthetic antibody libraries and uses therefor
12. 10889811 - Antibody libraries
13. 10882920 - Antibodies against BACE1 and use thereof for neural disease immunotherapy
14. 10196635 - Rationally designed, synthetic antibody libraries and uses therefor
15. 10189894 - Rationally designed, synthetic antibody libraries and uses therefor